Latest 10-K annual reports

Y-mAbs Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include Part III information and update the exhibit list, while also revising its non-employee director compensation policy.

Minerva Neurosciences files an amendment to its annual report to include missing Inline eXtensible Business Reporting Language (XBRL) data tagging.

FitLife Brands, Inc. files an amendment to its 2024 Annual Report on Form 10-K to restate information required by Items 10 through 15.

Starguide Group, Inc.'s 10-K filing reveals ongoing losses and a going concern uncertainty, but highlights the company's strategic shift towards becoming a SaaS incubator, with the acquisition of Live Investments Holdings and its LiveLead software.

Kairos Pharma, Ltd. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted exhibits related to securities description and executive compensation recovery policy.

Sentinel Holdings Ltd.'s 2024 10-K filing reveals a substantial revenue decline and a significant net loss, raising concerns about the company's financial stability and future operations.

Precigen files an amendment to its 2024 annual report to include information previously omitted from Part III, covering directors, executive officers, compensation, and corporate governance.

Nutriband Inc.'s 10-K filing reveals a widened net loss for fiscal year 2025, driven by increased research and development expenses for its AVERSA Fentanyl product and an impairment charge, despite a slight revenue increase.

Medalist Diversified REIT, Inc. files Amendment No. 1 to its Annual Report on Form 10-K/A, solely to amend and replace Part III of the Original Form 10-K.

DBV Technologies provides an overview of its ordinary shares, American Depositary Shares, corporate governance practices, and executive compensation in its amended 10-K filing.

Coya Therapeutics files an amendment to its annual report on Form 10-K/A to include previously omitted Part III information and updated certifications.

Evolv Technologies Holdings restates past financial statements following an investigation into sales practices and revenue recognition.

Ultralife Corporation files an amendment to its annual report on Form 10-K to include information on directors, executive officers, corporate governance, and executive compensation.

2seventy bio files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.

Rocket Companies files an amendment to its 2024 10-K report, detailing a planned Up-C structure collapse, acquisitions of Redfin and Mr. Cooper, and executive compensation.

XWELL, Inc. amends its original Form 10-K filing to include Part III information and updated certifications due to the absence of a definitive proxy statement.

Beeline Holdings files an amendment to its annual report on Form 10-K to include information required by Part III, which was initially omitted due to the delay in filing the definitive proxy statement.

Interpace Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information that was to be incorporated by reference from the company's definitive proxy statement.

Fossil Group files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, compensation, and related matters.

Canadian Pacific Kansas City (CPKC) filed an amendment to its 2024 Annual Report on Form 10-K/A to include Part III information regarding directors, executive officers, and corporate governance.

NEXT-ChemX Corporation files an amended 10-K/A report addressing auditor issues, restating financials due to a change in intangible asset valuation, and including a cybersecurity disclosure.

CERo Therapeutics Holdings files an amendment to its annual report to include information required by Part III of Form 10-K, covering details about directors, executive officers, compensation, and corporate governance.

Enzon Pharmaceuticals files an amendment to its 2024 Annual Report on Form 10-K to include Part III information and an updated certification from its principal executive and financial officer.

Glen Burnie Bancorp reports a net loss of $112,000 for 2024, while experiencing growth in its loan portfolio.

NV5 Global files an amendment to its 10-K annual report, providing details on directors, executive compensation, corporate governance, and related matters.

Via Renewables, Inc. files an amendment to its 2024 annual report to include required information in Part III (Items 10-14) regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Heritage Distilling Holding Company files an amendment to its 2024 annual report to include its Clawback Policy, which was inadvertently omitted in the original filing.

Quality Industrial Corp. achieves profitability in 2024, driven by the acquisition of Al Shola Gas, marking a significant turnaround from the previous year's losses.

Heritage Distilling Holding Company's 10-K filing reveals a year of strategic shifts, financial hurdles, and ongoing efforts to expand its market presence and brand recognition.

RadNet, Inc. amends its original Form 10-K filing to include the Insider Trading Policy, which was inadvertently omitted.